Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced successful mapping of the Respiratory Syncytial Virus (RSV) genome using its proprietary BioSeeker discovery engine to address one of global health’s most persistent and costly viral threats. By pinpointing highly conserved genomic targets, this mapping…
Galatea Bio and Fabric Genomics, a GeneDx company, announced today a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases. The initial offering will include an inherited cardiovascular gene panel based on American Heart Association (AHA) recommendations, with additional PRS for cardiovascular related…
AI meets genomics in BioAro’s latest launch, unlocking faster, scalable drug discovery.PanOmiQ Research sets a new global benchmark for precision health innovation. BIO International Convention In a bold move that may redefine the global future of genomics, drug discovery, and precision health, BioAro Inc., a Canadian biotechnology and precision medicine company, unveiled its expanded PanOmiQ platform today at the…
Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced the appointment of Dietrich Stephan, Ph.D. as Chair…